Veriheal

NOVEMBER 30, 2021

For the first time in over 50 years, a federal grant has been allocated for studying psychedelic treatment. The National Institutes of Health (NIH) awarded Johns Hopkins Medicine $4 million to investigate the therapeutic potential of psilocybin , particularly on tobacco addiction. The Government Gets Involved in Psychedelics .

Research and Development 98

Research and Development Therapy Data Treatment 98

Project CBD

FEBRUARY 28, 2023

HerbalGram, the acclaimed quarterly journal of the American Botanical Council, recently published its 2021 “Herb Market Report,” which included data on sales of CBD as an herbal ingredient in mainstream and natural retail channels in the United States. million more on CBD products in 2021 compared to 2017 — a 413.4%

CBD 144

CBD Seed-To-Sale Food Access 144

Cannabis Law Report

JUNE 26, 2019

“The purpose of this Programme is to facilitate compassionate access to cannabis for medical reasons, where conventional treatment has failed. Minister Byrne commented: “This is an important and positive step forward for those individuals who are suffering serious ill health but for whom conventional medicines are not working.”.

Medicine 55

Medicine Access Business Legislation 55

Healer

MARCH 26, 2021

Gresh has joined a growing number of patients who swear by medical cannabis not only as a treatment option for chronic pain, but also as a substitute for prescription opioids used in pain management. Opioids are a good medicine. I never thought that would have been possible,” he said. It doesn’t go away, but it becomes manageable.”.

Chronic Pain 86

Chronic Pain Clinical Trials Treatment Patients 86

Cannabis Law Report

JULY 2, 2021

Novel therapies and psychedelic treatments are rapidly gaining popularity across large swathes of North America as the awareness of mental health disorders and the revolutionary effects of psychedelics in their treatment become more mainstream. The company markets itself as the future of psychedelic medicine. for the SPY.

Research and Development 105

Research and Development Treatment Therapy Medicine 105

Cannabis Law Report

MAY 29, 2022

Widespread approval for psychedelic treatments remains unlikely, but the tide is slowly turning. In May 2021, a Nature Medicine study showed the benefits of MDMA in relieving post-traumatic stress disorder. [4] In May 2021, a Nature Medicine study showed the benefits of MDMA in relieving post-traumatic stress disorder. [4]

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Cannabis Law Report

JULY 28, 2021

Validates Cepharanthine’s potential in treating various cancers with unsatisfactory treatment options. Additionally, there were several instances in which cepharanthine displayed growth inhibition which was comparable or superior to current gold standard treatments, including colorectal, liver and skin cancers.

Research and Development 105

Research and Development Clinical Trials Treatment Pharmaceutical 105

CannaMD

NOVEMBER 6, 2019

Results further indicate that the presence of medicinal cannabis legislation appears to have no influence over opioid misuse. Some of the more interesting data on the relationship between opioids and medical marijuana for pain management comes from the field of orthopedic surgery. million to 11.4 More Information. Get Started.

Marijuana 87

Marijuana Patients Clinical Trials Data 87

Cannabis Law Report

JULY 24, 2022

The market launch of drugs containing MDMA for post-traumatic stress disorder (PTSD) or psilocybin for the treatment of depression is expected in the next five to ten years [1]. The market research company Data Bridge Market Research projects that the market capitalization of the psychedelic industry will grow 16.8 billion by 2029.

Research and Development 52

Research and Development Legalization Treatment Patients 52

TheAnswerPage

JANUARY 11, 2022

As reviewed in a recent Forbes article, “a study of more than 400 health care professionals has revealed that most physicians lack knowledge of medicinal cannabis, with 65% saying that they have been asked about medical marijuana as a treatment for chronic pain but were unable to answer their patients’ questions” (1).

Patients 98

Patients Education Marijuana Therapy 98

The Cannigma

JUNE 30, 2021

Since 2017, anyone in the Granite State in possession of less than three-quarters of an ounce of marijuana flower or five grams or less of hash or concentrates is subject to violation and not a criminal offense. In its early days medical marijuana may have been mainly known as a treatment for glaucoma, cancer, or AIDS. New Hampshire.

Chronic Pain 137

Chronic Pain Marijuana Conditions Patients 137

Cannabis Law Report

NOVEMBER 24, 2021

Medicinal cannabis has been legalised for use for a range of specified medical conditions in Australia since 2016. Focusing on professional medical publications, this study sought to investigate how medicinal cannabis is being represented in professional medical publications. The precis is simple. Background. Conclusions. Background.

Research and Development 52

Research and Development Medicine Access Media 52

MedicalJane

DECEMBER 13, 2017

Still, this did not convince many healthcare professionals to explore the medicinal benefits of the cannabis plant. However, some areas of the state remain underserved, as only 631 registered professionals are currently listed on the website as of December 11, 2017. Patience by all is emphasized at this time.

Programs 49

Programs Patients Chronic Pain Marijuana 49

Cannabis Law Report

SEPTEMBER 14, 2021

WHEREAS, a 2017 snapshot of the U.S. WHEREAS, in 2013, simple cannabis possession was the fourth most common cause of deportation for any offense and the most common cause of deportation for drug law violations; and. WHEREAS, the cannabis industry is likely to become a global multi-trillion dollar industry, with early U.S.

Policy 98

Policy Research and Development Access Cannabis 98

Cannabis Law Report

JUNE 8, 2022

MDMA-assisted therapy, a novel treatment for PTSD with FDA breakthrough therapy designation, is on track for NDA submission in 2023 pending results of the confirmatory Phase 3 trial. Experienced healthcare leaders bring decades of experience in global drug commercialization and patient access. He holds an M.B.A. from Carleton College.

Therapy 52

Therapy Treatment Access Patients 52

SpeedWeed

JULY 30, 2021

Data going back to 2005 is included in the commissioned report on the impacts of legalization, which was mandated by the Colorado General Assembly in 2013. . Furthermore, the measurement of available data elements can be affected by [the] very context of marijuana legalization. in 2015 to 6.7% in 2019,” the Colorado report stated.

Business 52

Business Data Safety Cannabinoids 52

SpeedWeed

JULY 30, 2021

Data going back to 2005 is included in the commissioned report on the impacts of legalization, which was mandated by the Colorado General Assembly in 2013. . Furthermore, the measurement of available data elements can be affected by [the] very context of marijuana legalization. in 2015 to 6.7% in 2019,” the Colorado report stated.

Retail 52

Retail Data Safety Cannabinoids 52

SpeedWeed

JULY 31, 2021

Data going back to 2005 is included in the commissioned report on the impacts of legalization, which was mandated by the Colorado General Assembly in 2013. . Furthermore, the measurement of available data elements can be affected by [the] very context of marijuana legalization. in 2015 to 6.7% in 2019,” the Colorado report stated.

Legalization 52

Legalization Data Safety Cannabinoids 52

SpeedWeed

JULY 30, 2021

Data going back to 2005 is included in the commissioned report on the impacts of legalization, which was mandated by the Colorado General Assembly in 2013. . Furthermore, the measurement of available data elements can be affected by [the] very context of marijuana legalization. in 2015 to 6.7% in 2019,” the Colorado report stated.

Data 52

Data Safety Cannabinoids Cannabis 52

SpeedWeed

JULY 30, 2021

Data going back to 2005 is included in the commissioned report on the impacts of legalization, which was mandated by the Colorado General Assembly in 2013. . Furthermore, the measurement of available data elements can be affected by [the] very context of marijuana legalization. in 2015 to 6.7% in 2019,” the Colorado report stated.

Dispensary 52

Dispensary Data Safety Cannabinoids 52

MJ Business Attorneys

JUNE 20, 2018

A 2017 research review report indicated evidence of certain oral cannabinoids’ effectiveness in both cancer prevention and treatment of chemotherapy-induced nausea and vomiting. JAMA Internal Medicine recently reported a 14% percent reduction in opioid prescriptions in the states that provide relaxed access to medical marijuana.

Banking 100

Banking Compliance Compliance Marijuana 100

Cannabis Law Report

APRIL 8, 2022

as a non-profit organization to fulfill the need to broaden psychedelic research, therapy, and develop legal options for psychedelic medicine. published the first edition of the MAPS Bulletin , titled “ MDMA Can Become a Legal Medicine ,” and the FDA rejected the second MDMA study protocol submitted by MAPS.

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

Cannabis Law Report

APRIL 12, 2019

So, we have an amazing medicine that patients are having success with for various ailments, many of which are very severe, and these Canadian patients can’t afford their medicine. We aim to continue to do more for the Canadian patients who choose to use medical cannabis as a treatment option. Medicine has no place on this list.

Access 45

Access Patients Marijuana Medicine 45

Cannabis Law Report

SEPTEMBER 22, 2019

“We all need to override this veto because as a practicing physician, right now, to not do so means that we are not practicing appropriate medicine in these cases.”. Lawmakers did not pass a bill that would have replaced the long list with “any condition for which treatment is determined to be necessary by a provider.”.

Conditions 40

Conditions Patients Decriminalization Programs 40

Cannabis Law Report

OCTOBER 29, 2019

The PK data on cats shows there are differences in absorption between cats and dogs and that dosing may be different between these two species and that our chew form is likely to be more absorbable than oils in general. Pharmacokinetics, Safety, and Clinical Efficacy of Cannabidiol Treatment in Osteoarthritic Dogs. Wakshlag, DVM, Ph.D.,

Safety 45

Safety CBD Clinical Trials Oil 45

CannaMD

SEPTEMBER 15, 2020

Where can you use your medicine and when are you at risk of getting arrested? SHORT ANSWER: In November 2016, the Florida Medical Marijuana Legalization Initiative (known as Amendment 2 ) legalized medical marijuana treatment in Florida. Check out CannaMD ‘s full list of medical marijuana treatment centers !).

Law 126

Law Marijuana Patients Treatment 126

CannaMD

SEPTEMBER 10, 2020

Data from the National Institute of Health indicates that younger women are more likely to use marijuana during pregnancy, with urine toxicology testing showing that 19% of pregnant women aged 18-25 screened positive for marijuana use. These numbers reflect both non-medical and medicinal marijuana use.

Marijuana 59

Marijuana Therapy Data THC 59

Cannabis Law Report

JUNE 11, 2019

This report provides an analysis of the latest data on the drug situation and responses to it across the European Union, Norway and Turkey. It is supported by other, online information resources, including our Statistical Bulletin, containing source data. This is a complex area. This is a complex area.

Medicine 40

Medicine Data THC Policy 40

The Cannigma

SEPTEMBER 15, 2022

As our body of research expands, new avenues of potential treatment emerge for conditions that were previously overlooked. 4 A 2020 rodent trial concluded that “clinical and preclinical data strongly support the involvement of the ECS” in the pathology of ASD” and its relevance to drug discovery.

Terpenes 91

Terpenes Strains Sleep THC 91

Weedistry

MARCH 8, 2019

In 2018, medical cannabis became legal in the UK after a nationwide outpouring of support for two young boys who rely on cannabis oil to treat their severe and rare forms of epilepsy, but lingering concerns around the safety and efficiency of the medicine mean that access is still heavily restricted. Results of the treatment.

Oil 40

Oil Treatment Patients THC 40

Freedom Leaf

JANUARY 4, 2018

After months of development, my partner and I built and successfully launched the beta for our cannabis data-analytics software, Jade Insights. It’s a software platform that helps cannabis businesses augment their process by providing insights for data-backed decision-making. ” JOHN KAGIA. ” OPHELIA CHONG.

Data 60

Data Policy Media Cannabis 60

The Joint Blog

DECEMBER 30, 2019

For the study, reported on by Reuters, researchers examined data collected from a total of almost 729,000 people aged 12 years and older between 2005 and 2017, including any prior-month cannabis use and any depression experienced over the previous year. of individuals without a recent history of depression”, states the report.

Marijuana 26

Marijuana Data History Medicine 26

Healer

APRIL 5, 2021

While there’s substantial human research that pharmaceutical combinations of CBD and THC can reduce pain, at the present time there’s much less data on CBD or CBD-dominant hemp products used alone for pain, but there are several small studies that suggest effectiveness, often at higher doses, according to Dr. Sulak.

CBD 98

CBD Chronic Pain Oil Topical 98

Cannabis Law Report

SEPTEMBER 19, 2019

Medicinal cannabis was technically legalised at the start of November 2018 following several high-profile cases about children with severe forms of epilepsy being unable to access potentially life-changing cannabis-based treatment. Yet, access to legal medicinal marijuana remains extremely limited. GW Pharmaceuticals ?and

Pharmaceutical 40

Pharmaceutical Research and Development Medicine Oil 40

Cannabis Law Report

JULY 12, 2019

Ultimately, the cannabinoid system works by way of multiple molecules affecting multiple receptors at once – the entourage effect, and thus such singular approaches to treatment by way of the cannabinoid system are not effective. If so, CBD medicines should warn of this at least for the purposes of drug testing. (32).

Extraction 73

Extraction Pharmaceutical CBD Epilepsy 73

CannaTech

JULY 19, 2018

In simple terms, the WHO is revisiting their stance on the safety and efficacy of cannabis as medicine; good news for countless legal, medical, and academic reasons. The critical review on CBD follows a November 2017 pre-review that concluded there is not enough evidence to justify the scheduling of CBD.

CBD 73

CBD Research and Development THC Patients 73

Cannabis Law Report

NOVEMBER 29, 2019

Delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) are the main chemicals used in medicine. When it comes to CBD, it shows promise as a potential new treatment for schizophrenia. In 2017, researchers from VA Palo Alto Health Care System revealed that THC can act as a sleep-aid for military veterans with PTSD.

Research and Development 59

Research and Development THC Cannabinoids CBD 59